Journal of Jilin University(Medicine Edition) ›› 2021, Vol. 47 ›› Issue (2): 528-536.doi: 10.13481/j.1671-587X.20210236
• Review • Previous Articles
Research progress in effect of histone demethylase in tumor progression
-
Received:2020-07-11Online:2021-03-28Published:2021-03-25
CLC Number:
- R34
Cite this article
share this article
| 1 | GALLINARI P， DI MARCO S， JONES P， et al. HDACs， histone deacetylation and gene transcription： from molecular biology to cancer therapeutics ［J］. Cell Res， 2007， 17（3）：195-211. |
| 2 | HABERLAND M， MONTGOMERY R L， OLSON E N. The many roles of histone deacetylases in development and physiology： implications for disease and therapy ［J］. Nat Rev Genet ， 2009， 10（1）：32-42. |
| 3 | CHAKRABARTI A， OEHME I， WITT O， et al. HDAC8： a multifaceted target for therapeutic interventions ［J］. Trends Pharmacol Sci， 2015， 36（7）：481-492. |
| 4 | AMIN S A， ADHIKARI N， JHA T. Structure-activity relationships of hydroxamate-based histone deacetylase-8 inhibitors： reality behind anticancer drug discovery ［J］. Future Med Chem，2017， 9（18）：2211-2237. |
| 5 | SOMOZA J R， SKENE R J， KATZ B A， et al. Structural snapshots of human HDAC8 provide insights into the class Ⅰ histone deacetylases ［J］. Structure， 2004 ， 12（7）：1325-1334. |
| 6 | DOWLING D P， GANTT S L， GATTIS S G， et al. Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors ［J］. Biochemistry，2008，47（51）：13554-13563. |
| 7 | VANNINI A， VOLPARI C， GALLINARI P， et al. Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex ［J］. EMBO Rep，2007，8（9）：879-884. |
| 8 | PORTER N J， CHRISTIANSON N H， DECROOS C， et al. Structural and functional influence of the glycine-rich loop G302 GGGY on the catalytic tyrosine of histone deacetylase 8［J］.Biochemistry，2016，55（48）：6718-6729. |
| 9 | ESTIU G， WEST N， MAZITSCHEK R， et al. On the inhibition of histone deacetylase 8 ［J］. Bioorg Med Chem，2010，18（11）：4103-4110. |
| 10 | GANTT S M， DECROOS C， LEE M S， et al. General base-general acid catalysis in human histone deacetylase 8 ［J］.Biochemistry，2016，55（5）：820-832. |
| 11 | TABACKMAN A A，FRANKSON R，MARSAN E S， et al.Structure of ‘linkerless’ hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket ［J］. J Struct Biol，2016，195（3）：373-378. |
| 12 | MAREK M， SHAIK T B， HEIMBURG T， et al. Characterization of histone deacetylase 8 （HDAC8） selective inhibition reveals specific active site structural and functional determinants ［J］. Med Chem， 2018，61（22）：10000-10016. |
| 13 | LOMBARDI P M，COLE K E，DOWLING D P，et al.Structure， mechanism， and inhibition of histone deacetylases and related metalloenzymes ［J］. Curr Opin Struct Biol， 2011， 21（6）：735-743. |
| 14 | LI Z M， ZHU W G. Targeting histone deacetylases for cancer therapy： from molecular mechanisms to clinical implications ［J］. Int J Biol Sci， 2014， 10（7）：757-770. |
| 15 | LEE H， REZAI-ZADEH N， SETO E. Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A ［J］. Mol Cell Biol，2004，24（2）：765-773. |
| 16 | NAKAGAWA M， ODA Y， EGUCHI T， et al. Expression profile of class I histonedeacetylases in human cancer tissues ［J］. Oncol Rep， 2007，18（4）：769-774. |
| 17 | SONG S Y， WANG Y， XU P， et al. The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma ［J］. Int J Oncol， 2015，47（5）：1819-1828. |
| 18 | WANG Y， XU P， YAO J， et al. MicroRNA-216b is Down-regulated in human gastric adenocarcinoma and inhibits proliferation and cell cycle progression by targeting oncogene HDAC8 ［J］. Targ Oncol， 2016， 11（6）：839. |
| 19 | SIEGEL R L，MILLER K D，JEMAL A.Cancer statistics，2019 ［J］. CA Cancer J Clin， 2019， 69（1）：7-34. |
| 20 | SAIJO H， HIROHASHI Y， TORIGOE T， et al. Plasticity of lung cancer stem-like cells is regulated by the transcription factor HOXA5 that is induced by oxidative stress［J］. Oncotarget，2016，7（31）：50043-50056. |
| 21 | LI Y， LIANG R， SUN M， et al. AMPK-dependent phosphorylation of HDAC8 triggers PGM1 expression to promote lung cancer cell survival under glucose starvation ［J］. Cancer Lett ， 2020 ， 478：82-92. |
| 22 | WU J， DU C L， LV Z， et al.The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma ［J］. Dig Dis Sci， 2013， 58（12）：3545-3553. |
| 23 | ZHU Y J， XU Q， SHAO M Y， et al. Decreased expression of HDAC8 indicates poor prognosis in patients with intrahepatic cholangiocarcinoma ［J］. Hepatobiliary Pancreat Dis Int，2019 ， 18（5）：464-470. |
| 24 | TIAN Y， WONG V W， WONG G L， et al. Histone Deacetylase HDAC8 promotes insulin resistance and β-catenin ativation in NAFLD-associated hepatocellular carcinoma［J］.Cancer Res， 2015， 75（22）：4803-4816. |
| 25 | BRAY F， FERLAY J， SOERJOMATARAM I， et al. Global cancer statistics 2018： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin， 2018，68（6）：394-424. |
| 26 | GOURD E. Low uptake of tamoxifen to prevent breast cancer ［J］. Lancet Oncol，2018，19（6）：E290. |
| 27 | KANG J， SOHN J S， LEE H Y， et al. Histone deacetylases 1， 6 and 8 are critical for invasion in breast cancer ［J］. Oncol Rep， 2011，25（6）：167. |
| 28 | MENBARI M N， RAHIMI K， AHMADI A， et al. Abdi M. miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene ［J］. J Cell Physiol， 2020，235（3）：2631-2642. |
| 29 | CHIU C F， CHIN H K， HUANG W J， et al. Induction of apoptosis and autophagy in breast cancer cells by a novel HDAC8 inhibitor ［J］. Biomolecules，2019，9（12）：824. |
| 30 | JANA S， SENGUPTA S， BISWAS S， et al. miR-216b suppresses breast cancer growth and metastasis by targeting SDCBP ［J］. Biochem Biophys Res Commun， 2017，482（1）：126-133. |
| 31 | MENBARI M N， RAHIMI K， AHMADI A， et al. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression ［J］. Life Sci，2019，237：116945. |
| 32 | OEHME I， DEUBZER H E， WEGENER D， et al. Histone deacetylase 8 in neuroblastoma tumorigenesis ［J］. Clin Cancer Res， 2009， 15（1）：91-99. |
| 33 | OEHME I， DEUBZER H E， LODRINI M， et al. Targeting of HDAC8 and investigational inhibitors in neuroblastoma ［J］. Expert Opin Investig Drugs，2009， 18（11）：1605-1617. |
| 34 | RETTIG I， KOENEKE E， TRIPPEL F， et al. Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation ［J］. Cell Death Dis， 2015（2）：e1657. |
| 35 | SHEN J， NAJAFI S， STÄBLE S， et al. A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment ［J］. Cell Death Differ，2018，25（12）：2053‐2070. |
| 36 | PRASHAD N. miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth ［J］. Oncotarget，2018，9（69）：33186-33201. |
| 37 | KOLBINGER F R， KOENEKE E， RIDINGER J， et al. The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines ［J］. Arch Toxicol，2018，92（8）：2649-2664. |
| 38 | BISWAS S， REDDY N D， JAYASHREE B S， et al. Evaluation of novel 3-hydroxyflavone analogues as HDAC inhibitors against colorectal cancer ［J］. Adv Pharmacol Sci， 2018，2018：4751806. |
| 39 | YAN W， LIU S， XU E， et al. Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8 ［J］. Oncogene，2013， 32（5）：599-609. |
| 40 | KANG Y， NIAN H， RAJENDRAN P， et al. HDAC8 and STAT3 repress BMF gene activity in colon cancer cells ［J］. Cell Death Dis，2014，5：e1476. |
| 41 | ZHANG B J， LIU B， CHEN D， et al. Histone Deacetylase inhibitors sensitize TRAIL-induced apoptosis in colon cancer cells［J］.Cancers，2019，11（5）：645. |
| 42 | DOHNER H， ESTEY E H， AMADORI S， et al. Diagnosis and management of acute myeloid leukemia in adults： recommendations from an international expert panel， on behalf of the European Leukemia Net［J］. Blood，2010，115（3）：453-474. |
| 43 | LONG J， JIA M Y， FANG W Y， et al. FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia ［J］. Blood，2020，135（17）：1472-1483. |
| 44 | GHAZY E， ZEYEN P， HERP D， et al. Design， synthesis， and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1 ［J］. Eur J Med Chem，2020，200：112338. |
| 45 | TASHI T， SWIERCZEK S， PRCHAL J T. Familial MPN predisposition ［J］. Curr Hematol Malig Rep， 2017，12（5）：442-447. |
| 46 | GAO S M， CHEN C Q， WANG L Y， et al. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms［J］. Exp Hematol，2013， 41（3）：261-270.e4. |
| 47 | RAMOS T L， SÁNCHEZ-ABARCA L I， REDONDO A， et al. HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms： a new therapeutic target？［J］.Oncotarget，2017，8（17）：28187-28202. |
| 48 | SIMOBEN C V， ROBAA D， CHAKRABARTI A， et al. A novel class of schistosoma mansoni histone deacetylase 8 （HDAC8） inhibitors identified by structure-based virtual screening and in vitro testing ［J］. Molecules，2018，23（3）：566. |
| 49 | YAMAUCHI Y， BOUKARI H， BANERJEE I， et al. Histone deacetylase 8 is required for centrosome cohesion and influenza A virus entry ［J］. PLoS Pathog， 2011，7（10）：e1002316. |
| 50 | BERTRAND P. Inside HDAC with HDAC inhibitors ［J］. Eur J Med Chem， 2010，45（6）：2095-2116. |
| 51 | 李 群，王 剑，王秀敏.德朗热综合征的分子机制及诊治研究进展［J］. 医学综述， 2019，25（8）：1614-1619. |
| 52 | DEARDORFF M A， BANDO M， NAKATO R， et al. HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle［J］.Nature，2012，489（7415）：313-317. |
| 53 | AMIN S A， ADHIKARI N， JHA T. Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies？ ［J］. Pharmacol Res，2017，122：8-19. |
| 54 | AMIN S A， ADHIKARI N， JHA T. Diverse classes of HDAC8 inhibitors： in search of molecular fingerprints that regulate activity ［J］.Future Med Chem，2018，10（13）：1589-1602. |
| 55 | BALASUBRAMANIAN S， VERNER E， BUGGY J J. Isoform-specific histone deacetylase inhibitors： the next step？ ［J］. Cancer Lett，2009， 280（2）：211-221 |
| 56 | AMIN S A， ADHIKARI N， JHA T. Structure-activity relationships of hydroxamate-based histone deacetylase-8 inhibitors： reality behind anticancer drug discovery ［J］. Future Med Chem， 2017， 9（18）：2211-2237. |
| 57 | SODJI Q H， KORNACKI J R， MCDONALD J F，et al.Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids ［J］.Eur J Med Chem，2015，96：340-359. |
| 58 | KALININ D V， JANA S K， PFAFENROT M， et al. Front cover：structure-based design， synthesis， and biological evaluation of triazole-based smHDAC8 Inhibitors ［J］. Chem Med Chem，2020，15（7）：559. |
| 59 | WOLFF B， JÄNSCH N， SUGIARTO W O， et al. Synthesis and structure activity relationship of 1，3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors ［J］. Eur J Med Chem， 2019， 184：111756. |
| 60 | WHITEHEAD L，DOBLER M R，RADETICH B，et al.Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors ［J］. Bioorg Med Chem， 2011， 19（15）：4626-4634. |
| 61 | INGHAM O J， PARANAL R M， SMITH W B， et al. Development of a potent and selective HDAC8 inhibitor ［J］. ACS Med Chem Lett， 2016，7（10）：929-932. |
| 62 | WÜNSCH M， SENGER J， SCHULTHEISZ P， et al. Structure-activity relationship of propargylamine-based HDAC inhibitors ［J］. Chem Med Chem，2017，12（24）： 2044-2053. |
| 63 | ZHAO C， ZANG J， DING Q， et al. Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors ［J］. Eur J Med Chem，2018， 150：282-291. |
| 64 | LAMAA D， LIN H P， ZIG L， et al. Design and Synthesis of tubulin and histone deacetylase inhibitor based on iso-combretastatin A-4 ［J］.Med Chem，2018，61（15）：6574-6591. |
| 65 | ADHIKARI N， AMIN S A， JHA T. Selective and nonselective HDAC8 inhibitors： a therapeutic patent review ［J］. Pharm Pat Anal，2018，7（6）：259-276. |
| *延边大学医学院2017级麻醉学专业 |
| [1] | Ye YUAN,Jinbao ZHUANG,Xu SHI,Changyuan LI. Influence of PGE2 on PD-1 expression in infiltrating T lymphocytes in non-small cell lung cancer tissue and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 249-256. |
| [2] | LI Shengnan, WANG Mengxu, HU Weidong, CHEN Shaofeng, CHEN Xinglan, LI You. Construction and identification of miR-186 overexpression lentiviral vector [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 997-1002. |
| [3] | . Research progress in role of mechanosensitive ion channel protein Piezo in mechanical transduction [J]. Journal of Jilin University(Medicine Edition), 2019, 45(03): 725-730. |
| [4] | SHI Xu, YU Xin, QU Xinglong, CAO Yang, ZHANG Guangjuan, LI Changyuan. Effects of hypoxia and its downstream factor mirRNA-145 on differentiation of umbilical cord mesenchymal stem cells into type Ⅱ alveolar epithelial cells [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 935-942. |
| [5] | . Research progress in function of cell division cycle protein Cdc14A [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 1105-1108. |
| [6] | XI Yanli, XU Na, LI Shu, WANG Di, WANG Shuran, NIU Fenglan. Inhibitory effect of gallic acid on proliferation of human non-small cell lung cancer A549 cells [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1092-1098. |
| [7] | ZHANG Yanqiu, WANG Chunsheng, WANG Kunzheng, JIANG Zhaolong. Influence of long term application glucocorticoid on expressions of HMGB1,RAGE,OPG and RANKL in bone tissue of rats [J]. Journal of Jilin University Medicine Edition, 2015, 41(05): 907-913. |
| [8] | PAN Tao, GUO Caixia, JIN Minghua, LIU Xiaomei, LIU Ying, DU Haiying, SUN Zhiwei. Cytotoxicity of SiO2 nanoparticles on liver HL-7702 cells [J]. Journal of Jilin University Medicine Edition, 2015, 41(05): 885-890. |
| [9] | . Advance research on new calcium channels TRPV5 and TRPV6 [J]. Journal of Jilin University Medicine Edition, 2013, 39(3): 634-637. |
| [10] | ZHOU Jia-qi,LU Jia-rui*,XU Hua,HAN Fang,SUN Yan-bo. Detection of aminoglycoside modifying enzyme genes in gram-negative bacilli from some hospitals in Changchun area [J]. Journal of Jilin University Medicine Edition, 2013, 39(2): 405-409. |
| [11] | . Expressions |of Galectin-3 and integrin ανβ3 mRNA in glioma cells and their significances [J]. J4, 2012, 38(5): 973-976. |
| [12] | ZHANG Hong-mei,LIANG Mei,LIU Ping,WU Ting-ting,GUO Shu-liang. Interaction between mycobacteriophage D29 and macrophages and its mechanism [J]. J4, 2012, 38(2): 230-236. |
| [13] | LIU Yue,LI Jing-hua,SHI Hong-yan,WEN Jian-ping,SUN Yan-bo. Biological characteristics of enterohemorrhagic E. coliO157-specific bacteriophages isolated from raw sewage [J]. J4, 2012, 38(1): 79-83. |
| [14] | LIANG-Yu,LI-Na,XU Hong-mei,HE Jin. Application of FISH technique in chromosome detection for missed abortion and dead fetus tissues [J]. J4, 2012, 38(1): 127-130. |
| [15] | LUO Dan,XIANG Yan-gen,PAN Jian-hua,PENG Xue-feng,DENG Wei-zhi,SHI Guo-min. Detection of |three-drug resistance related genes of mycobacterium tuberculosis by |membrance reverse dot blot hybridization [J]. J4, 2011, 37(4): 759-762. |
|